Meyer Handelman Company’s Elevance Health ELV Stock Holding History

Meyer Handelman Company’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-700	Closed	-$245K	–	225
2025 Q4	$245K	Hold	700	–	–	0.01%	203
2025 Q3	$226K	Hold	700	–	–	0.01%	207
2025 Q2	$272K	Hold	700	–	–	0.01%	199
2025 Q1	$304K	Hold	700	–	–	0.01%	189
2024 Q4	$258K	Hold	700	–	–	0.01%	197
2024 Q3	$364K	Hold	700	–	–	0.01%	186
2024 Q2	$379K	Sell	700 -100	-13%	-$52.9K	0.01%	180
2024 Q1	$415K	Hold	800	–	–	0.01%	179
2023 Q4	$377K	Hold	800	–	–	0.01%	170
2023 Q3	$348K	Hold	800	–	–	0.01%	174
2023 Q2	$355K	Hold	800	–	–	0.01%	170
2023 Q1	$368K	Hold	800	–	–	0.02%	168
2022 Q4	$410K	Hold	800	–	–	0.02%	163
2022 Q3	$363K	Hold	800	–	–	0.02%	167
2022 Q2	$386K	Hold	800	–	–	0.02%	168
2022 Q1	$393K	Hold	800	–	–	0.02%	169
2021 Q4	$371K	Hold	800	–	–	0.01%	169
2021 Q3	$298K	Hold	800	–	–	0.01%	185
2021 Q2	$305K	Hold	800	–	–	0.01%	194
2021 Q1	$287K	Hold	800	–	–	0.01%	191
2020 Q4	$257K	Hold	800	–	–	0.01%	183
2020 Q3	$215K	Sell	800 -1,300	-62%	-$350K	0.01%	178
2020 Q2	$552K	Hold	2,100	–	–	0.03%	159
2020 Q1	$477K	Hold	2,100	–	–	0.03%	151
2019 Q4	$634K	Hold	2,100	–	–	0.03%	157
2019 Q3	$504K	Hold	2,100	–	–	0.03%	162
2019 Q2	$593K	Hold	2,100	–	–	0.03%	159
2019 Q1	$622K	Hold	2,100	–	–	0.03%	153
2018 Q4	$552K	Hold	2,100	–	–	0.03%	152
2018 Q3	$576K	Hold	2,100	–	–	0.03%	158
2018 Q2	$500K	Hold	2,100	–	–	0.03%	166
2018 Q1	$461K	Hold	2,100	–	–	0.02%	166
2017 Q4	$473K	Hold	2,100	–	–	0.02%	164
2017 Q3	$399K	Hold	2,100	–	–	0.02%	169
2017 Q2	$395K	Hold	2,100	–	–	0.02%	166
2017 Q1	$347K	Hold	2,100	–	–	0.01%	167
2016 Q4	$302K	Hold	2,100	–	–	0.01%	171
2016 Q3	$263K	Hold	2,100	–	–	0.01%	175
2016 Q2	$276K	Hold	2,100	–	–	0.01%	177
2016 Q1	$292K	Hold	2,100	–	–	0.01%	182
2015 Q4	$293K	Hold	2,100	–	–	0.01%	181
2015 Q3	$294K	Hold	2,100	–	–	0.01%	180
2015 Q2	$345K	Hold	2,100	–	–	0.02%	174
2015 Q1	$324K	Hold	2,100	–	–	0.01%	178
2014 Q4	$264K	Hold	2,100	–	–	0.01%	186
2014 Q3	$251K	Hold	2,100	–	–	0.01%	179
2014 Q2	$226K	Hold	2,100	–	–	0.01%	182
2014 Q1	$209K	Buy	+2,100	New	+$190K	0.01%	184

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Meyer Handelman Company's ELV Position: Q1 2026 in Review

Meyer Handelman Company sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 700 shares — an estimated $245K sold.

Meyer Handelman Company first reported a position in ELV in Q1 2014 and held it in 48 quarters. The position peaked at $634K in Q4 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Meyer Handelman Company reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
Meyer Handelman Company sold 700 Elevance Health shares in Q1 2026, an estimated $245K.
Meyer Handelman Company first reported a position in Elevance Health in Q1 2014 and held it in 48 quarters.
Meyer Handelman Company's Elevance Health position peaked at $634K in Q4 2019.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.